Literature DB >> 2566498

Effects of adrenalectomy on responses mediated by dopamine D-1 and D-2 receptors.

J E Faunt1, A D Crocker.   

Abstract

The effects of surgical adrenalectomy were investigated on behavioural responses produced by the selective D-1 agonist, SK&F 38393, alone, and in combination with the D-2 agonist, quinpirole (LY171555). Further, stereotyped responses to apomorphine and LY171555 were assessed following treatment with either the D-1 or the D-2 antagonists, SCH 23390 and raclopride, respectively. There was no difference between sham-adrenalectomized (sham) and adrenalectomized (ADX) groups in responses to SK&F 38393. Although concomitant stimulation of both receptor subtypes increased the incidence of stereotyped sniffing behaviour, there was no difference in the magnitude of this effect between the sham and ADX groups. Raclopride reduced LY171555-induced sniffing and hypothermia less in ADX rats than in sham controls, which was consistent with the hypothesis that adrenocortical hormones affect D-2 receptor responsiveness. SCH 23390 had a greater inhibitory effect on LY171555 responses, but a smaller effect on apomorphine responses in the ADX group compared with their sham controls. It is concluded that the amplified D-2-stimulated response observed in ADX rats may be more dependent on tonic D-1 receptor activation than the control D-2 response of shams.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566498     DOI: 10.1016/0014-2999(89)90286-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Changes in pituitary-adrenal activity affect the apomorphine- and cholecystokinin-8-induced changes in striatal dopamine release using microdialysis.

Authors:  S Tanganelli; K Fuxe; G von Euler; P Eneroth; L F Agnati; U Ungerstedt
Journal:  J Neural Transm Gen Sect       Date:  1990

2.  Pramipexole alters thermoregulation in restless legs syndrome.

Authors:  Aaro V Salminen; Ville Rimpilä; Olli Polo
Journal:  J Clin Sleep Med       Date:  2014-12-15       Impact factor: 4.062

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.